Concepedia
The Journal of Rheumatology · 2021 · 14 citations · 23 references
No clinical benefit was observed with apremilast treatment in patients with active AS. The safety and tolerability of apremilast were consistent with its known profile.
23
Evaluation of Diagnostic Criteria for Ankylosing Spondylitis
Sjef van der Linden, Hans A. Valkenburg, A. Cats · Arthritis & Rheumatism · 1984 · 5.6K citations
A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.
Sylvester Garrett, T Jenkinson, L G Kennedy et al. · PubMed · 1994 · 3.2K citations
A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.
A Cãlin, H Whitelock, L G Kennedy et al. · PubMed · 1994 · 1.8K citations
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis
Joachim Sieper, Martín Rudwaleit, Xenofon Baraliakos et al. · Annals of the Rheumatic Diseases · 2009 · 1.6K citations
Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis
Cédric Lukas, Robert Landewé, Joachim Sieper et al. · Annals of the Rheumatic Diseases · 2008 · 1K citations